Type 1 diabetes

Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I

BMJ Open Diabetes Res CarePublished Longitudinal observational cohort study

Main finding · All-cause deathResult — go to the resultMRR 3.04 95% CI 2.13–4.31

Authors' conclusion

T1D substantially increases the risk of death, especially when diagnosed in late adolescence/young adulthood. Diabetes type does not influence mortality after adjustment for key confounding variables.

Study context

Population
Community-based Australians with T1D, Fremantle Diabetes Study Phase I, entry 1993–1996, followed to death/end-2017; pooled mean±SD age 43.1±15.3 years, 59.2% men12,541 person-years
Exposure
T1D vs no diabetes
  • T1Dn = 121
  • Without diabetesn = 484reference
Outcome
All-cause mortality (mortality rates (MRs) and mortality rate ratios (MRRs))
Follow-up
Entry (1993-1996) to death/end-2017
Methodological detailscommunity-based, age/sex/postcode-matched
  • Community-based
  • Age/sex/postcode-matched

Main finding

All-cause death

MRR

3.04

95% CI 2.13–4.31

P < 0.001

Events by group

As reported in the abstract

Observational data: associations, not effects.

Further findings

OutcomeHR (95% CI)P value
Mortality, pooled Cox regression (T1D vs T2D)Adjusted1.18 (0.71–1.97)P = 0.523
OutcomeT1DWithout diabetesT2DMRR (95% CI)P value
CVD deathT1D vs Without diabetes4.34 (2.43–7.73)P < 0.001
MR /1000 person-years11.7 (95% CI 7.6 to 17.3)2.7 (95% CI 1.8 to 3.9)— not stated in the abstract
Death, T1D vs age/sex-matched T2D57.0%— not stated in the abstract39.8%P = 0.027

— not stated in the abstract

  • Death, T1D vs age/sex-matched T2D: 93 matched pairs

Independent predictors of death in T1D

Diagnosis at age 18-27 years and baseline HbA1c, urinary albumin:creatinine ratio and retinopathy were independent predictors of death
P ≤ 0.011

Original publication

Comparative mortality and its determinants in community-based people with type 1 diabetes: the Fremantle Diabetes Study Phase I. BMJ Open Diabetes Res Care. Published 24 July 2023. doi:10.1136/bmjdrc-2023-003501

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.